SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

GLPG

28.84

+0.7%↑

ICAD

21.18

+1.92%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

GLPG

28.84

+0.7%↑

ICAD

21.18

+1.92%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

GLPG

28.84

+0.7%↑

ICAD

21.18

+1.92%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

GLPG

28.84

+0.7%↑

ICAD

21.18

+1.92%↑

SRT3

178.35

-1%↓

ORNBV.FI

71.3

+0.49%↑

ROVI.ES

53.1

-0.28%↓

GLPG

28.84

+0.7%↑

ICAD

21.18

+1.92%↑

Search

Opmobility

Закрыт

СекторЗдравоохранение

12.9 0.08

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

12.58

Макс.

12.95

Ключевые показатели

By Trading Economics

Доход

21M

91M

Продажи

261M

5.3B

P/E

Средняя по отрасли

11.339

40.048

Дивидендная доходность

2.69

Рентабельность продаж

1.707

Сотрудники

29,213

EBITDA

377M

Рекомендации

By TipRanks

Рекомендации

Нейтрально

Прогноз на 12 месяцев

-2.5% downside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

2.69%

2.45%

Рыночная статистика

By TradingEconomics

Рыночная капитализация

166M

1.9B

Предыдущая цена открытия

12.82

Предыдущая цена закрытия

12.9

Новостные настроения

By Acuity

40%

60%

138 / 374 Рейтинг в Healthcare

Opmobility График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

4 авг. 2025 г., 21:42 UTC

Отчет
Приобретения, слияния, поглощения

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 авг. 2025 г., 21:21 UTC

Отчет
Главные движущие силы рынка

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 авг. 2025 г., 20:45 UTC

Отчет

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 авг. 2025 г., 19:15 UTC

Главные движущие силы рынка

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 авг. 2025 г., 23:41 UTC

Обсуждения рынка

Global Forex and Fixed Income Roundup: Market Talk

4 авг. 2025 г., 23:41 UTC

Обсуждения рынка

Nikkei May Rise on Fed Stimulus Hopes

4 авг. 2025 г., 23:28 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

4 авг. 2025 г., 23:28 UTC

Обсуждения рынка

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 авг. 2025 г., 21:30 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 авг. 2025 г., 21:21 UTC

Отчет
Приобретения, слияния, поглощения

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 авг. 2025 г., 21:18 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 авг. 2025 г., 20:25 UTC

Обсуждения рынка

India Hits Back Over Russian Oil Purchases -- Market Talk

4 авг. 2025 г., 20:25 UTC

Отчет

Transocean 2Q Loss $938M >RIG

4 авг. 2025 г., 20:25 UTC

Отчет

Transocean 2Q Loss/Shr $1.06 >RIG

4 авг. 2025 г., 20:18 UTC

Отчет

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 авг. 2025 г., 20:15 UTC

Отчет

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 авг. 2025 г., 20:14 UTC

Отчет

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 авг. 2025 г., 20:13 UTC

Отчет

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 авг. 2025 г., 20:09 UTC

Отчет

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 авг. 2025 г., 20:06 UTC

Отчет

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 авг. 2025 г., 20:01 UTC

Отчет

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 авг. 2025 г., 19:41 UTC

Обсуждения рынка

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 авг. 2025 г., 19:28 UTC

Обсуждения рынка

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 авг. 2025 г., 19:07 UTC

Обсуждения рынка

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 авг. 2025 г., 18:27 UTC

Обсуждения рынка

Gold Climbs on Rate Cut Speculation -- Market Talk

Сравнение c конкурентами

Изменение цены

Opmobility Прогноз

Целевая цена

By TipRanks

-2.5% падение

Прогноз на 12 месяцев

Средняя 12.86 EUR  -2.5%

Максимум 15 EUR

Минимум 7.4 EUR

Основано на мнении 7 аналитиков Wall Street, спрогнозировавших целевые цены для Opmobility на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Нейтрально

7 ratings

2

Покупка

3

Удержание

2

Продажа

Настроения

By Acuity

138 / 374Рейтинг в Здравоохранение

Новостные настроения

Свидетельства восходящего тренда

Волатильность

Ниже среднего

Объем новостей (RCV)

Выше среднего

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании Opmobility

OPmobility SE engages in the manufacture and sale of exterior vehicle lighting systems, batteries, and electrification systems for electric mobility in Europe, North America, China, rest of Asia, South America, the Middle East, and Africa. The company operates through three segments: Exterior Systems, Modules, and Powertrain. Its Exterior Systems segment provides intelligent exterior systems; and automotive lighting systems, headlights, and signal lighting to intelligent, and other lighting products. The company's Powertrain segment offers clean energy systems comprising energy storage and emission reduction systems for various types of gasoline, diesel, hybrid, and plug-in hybrid powertrains; designs and manufactures battery systems, electronics, and power electronics components for electric mobility of trucks, buses, trains, and construction machineries. This segment also designs and manufactures hydrogen solutions, including high-pressure fuel tanks, fuel cell stacks, and integrated systems. Its Modules segment engages in the design, development, and assemble of modules (HBPO). In addition, the company provides intelligent exterior systems, including bumpers, tailgates and spoilers, and body panels; onboard energy storage and emission reduction systems comprising selective catalytic reduction and fuel systems, and filling pipes. Further, it offers modules and personalization products, which include front-end module, active grille shutter, active rollo, and interior and charge lid modules; and lighting solutions, including interior, body shell, and front and signal lighting, as well as projection system and lighting electronics. The company was formerly known as Compagnie Plastic Omnium SE and changed its name to OPmobility SE in March 2024. The company was founded in 1946 and is headquartered in Levallois-Perret, France. OPmobility SE is a subsidiary of Burelle SA.